Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients

Nitric Oxide - Biology and Chemistry

Volumn 16, Issue 3, 2007, Pages 348-355

  Sandrim, Valeria C ^a   de Syllos, Roger W C ^b   Lisboa, Hugo R K ^c   Tres, Glaucia S ^c   Tanus Santos, Jose E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF PASSO FUNDO   (Brazil)

Author keywords

Endothelial nitric oxide synthase; Genotypes; Haplotypes; Hypertension; Nitrate; Nitric oxide; Nitrite; Polymorphisms

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; ALLELE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIABETIC PATIENT; DRUG BLOOD LEVEL; ENZYME POLYMORPHISM; EXON; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; INTRON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROMOTER REGION; RISK;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; ISOENZYMES; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 34047168287     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2006.12.007     Document Type: Article

References (44)

1. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N. Engl. J. Med. 329 (1993) 2002-2012
2. Hingorani A.D. Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis 154 (2001) 521-527
3. Nagassaki S., Metzger I.F., Souza-Costa D.C., Marroni A.S., Uzuelli J.A., and Tanus-Santos J.E. eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population. Thromb. Res. 115 (2005) 375-379
4. Metzger I.F., Souza-Costa D.C., Marroni A.S., Nagassaki S., Desta Z., Flockhart D.A., and Tanus-Santos J.E. Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet. Genomics 15 (2005) 565-570
5. Wang X.L., Mahaney M.C., Sim A.S., Wang J., Blangero J., Almasy L., Badenhop R.B., and Wilcken D.E. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 3147-3153
6. Wang X.L., and Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol. Genet. Metab. 70 (2000) 241-251
7. McDonald .D.M., Alp N.J., and Channon K.M. Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells. Pharmacogenetics 14 (2004) 831-839
8. Nakayama M., Yasue H., Yoshimura M., Shimasaki Y., Kugiyama K., Ogawa H., Motoyama T., Saito Y., Ogawa Y., Miyamoto Y., and Nakao K. T-786 -->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99 (1999) 2864-2870
9. Tanus-Santos J.E., Desai M., Deak L.R., Pezzullo J.C., Abernethy D.R., Flockhart D.A., and Freedman J.E. Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics 12 (2002) 407-413
10. Ou H., Shen Y.H., Utama B., Wang J., Wang X., Coselli J., and Wang X.L. Effect of nuclear actin on endothelial nitric oxide synthase expression. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2509-2514
11. Hibbs Jr. J.B., Westenfelder C., Taintor R., Vavrin Z., Kablitz C., Baranowski R.L., Ward J.H., Menlove R.L., McMurry M.P., Kushner J.P., et al. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89 (1992) 867-877
12. Baylis C., and Vallance P. Measurement of nitrite and nitrate levels in plasma and urine--what does this measure tell us about the activity of the endogenous nitric oxide system?. Curr. Opin. Nephrol. Hypertens. 7 (1998) 59-62
13. Moon J., Yoon S., Kim E., Shin C., Jo S.A., and Jo I. Lack of evidence for contribution of Glu298Asp (G894T) polymorphism of endothelial nitric oxide synthase gene to plasma nitric oxide levels. Thromb. Res. 107 (2002) 129-134
14. Hassan A., Gormley K., O'Sullivan M., Knight J., Sham P., Vallance P., Bamford J., and Markus H. Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 35 (2004) 654-659
15. Nasreen S., Nabika T., Shibata H., Moriyama H., Yamashita K., Masuda J., and Kobayashi S. T-786C polymorphism in endothelial NO synthase gene affects cerebral circulation in smokers: possible gene-environmental interaction. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 605-610
16. Jeerooburkhan N., Jones L.C., Bujac S., Cooper J.A., Miller G.J., Vallance P., Humphries S.E., and Hingorani A.D. Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease. Hypertension 38 (2001) 1054-1061
17. Miyamoto Y., Saito Y., Nakayama M., Shimasaki Y., Yoshimura T., Yoshimura M., Harada M., Kajiyama N., Kishimoto I., Kuwahara K., Hino J., Ogawa E., Hamanaka I., Kamitani S., Takahashi N., Kawakami R., Kangawa K., Yasue H., and Nakao K. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T-C mutation associated with coronary spastic angina. Hum. Mol. Genet. 9 (2000) 2629-2637
18. Tsukada T., Yokoyama K., Arai T., Takemoto F., Hara S., Yamada A., Kawaguchi Y., Hosoya T., and Igari J. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Commun. 245 (1998) 190-193
19. Yoon Y., Song J., Hong S.H., and Kim J.Q. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin. Chem. 46 (2000) 1626-1630
20. Sambrook J., and Russell D. Molecular Cloning; a Laboratory Manual. Third ed. (2001), Cold Spring Harbor Laboratory, New York
21. Marroni A.S., Metzger I.F., Souza-Costa D.C., Nagassaki S., Sandrim V.C., Correa R.X., Rios-Santos F., and Tanus-Santos J.E. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12 (2005) 177-182
22. Barbosa Jr. F., Sandrim V.C., Uzuelli J.A., Gerlach R.F., and Tanus-Santos J.E. eNOS genotype-dependent correlation between whole blood lead and plasma nitric oxide products concentrations. Nitric Oxide 14 (2006) 58-64
23. Sandrim V.C., de Syllos R.W.C., Lisboa H.R.K., Tres G.S., and Tanus-Santos J.E. Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 189 (2006) 241-246
24. Tanus-Santos J.E., Desai M., and Flockhart D.A. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11 (2001) 719-725
25. Sandrim V.C., Coelho E.B., Nobre F., Arado G.M., Lanchote V.L., and Tanus-Santos J.E. Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 186 (2006) 428-432
26. Wang X., Tanus-Santos J.E., Reiter C.D., Dejam A., Shiva S., Smith R.D., Hogg N., and Gladwin M.T. Biological activity of nitric oxide in the plasmatic compartment. Proc. Natl. Acad. Sci. USA 101 (2004) 11477-11482
27. Sandrim V.C., Yugar-Toledo J.C., Desta Z., Flockhart D.A., Moreno Jr. H., and Tanus-Santos J.E. Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy. J. Hypertens. 24 (2006) 2393-2397
28. Crawford D.C., and Nickerson D.A. Definition and clinical importance of haplotypes. Annu. Rev. Med. 56 (2005) 303-320
29. Zhao Q., Su S.Y., Chen S.F., Li B., and Gu D.F. Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese. Chin. Med. J. (Engl.) 119 (2006) 1065-1071
30. Serrano N.C., Casas J.P., Diaz L.A., Paez C., Mesa C.M., Cifuentes R., Monterrosa A., Bautista A., Hawe E., Hingorani A.D., Vallance P., and Lopez-Jaramillo P. Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control study. Hypertension 44 (2004) 702-707
31. Colombo M.G., Paradossi U., Andreassi M.G., Botto N., Manfredi S., Masetti S., Biagini A., and Clerico A. Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin. Chem. 49 (2003) 389-395
32. Rhodes P., Leone A.M., Francis P.L., Struthers A.D., Moncada S., and Rhodes P.M. The l-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem. Biophys. Res. Commun. 209 (1995) 590-596
33. Forte P., Copland M., Smith L.M., Milne E., Sutherland J., and Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 349 (1997) 837-842
34. Tsuda K., and Nishio I. Leptin and nitric oxide production in normotensive and hypertensive men. Obes. Res. 12 (2004) 1223-1237
35. Node K., Kitakaze M., Yoshikawa H., Kosaka H., and Hori M. Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension 30 (1997) 405-408
36. Kelm M., Feelisch M., Deussen A., Strauer B.E., and Schrader J. Release of endothelium derived nitric oxide in relation to pressure and flow. Cardiovasc. Res. 25 (1991) 831-836
37. Kohno M., Yokokawa K., Minami M., Yasunari K., Maeda K., Kano H., Hanehira T., and Yoshikawa J. Plasma levels of nitric oxide and related vasoactive factors following long-term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertension. Metabolism 48 (1999) 1256-1259
38. Wang J., Dudley D., and Wang X.L. Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler. Thromb. Vasc. Biol. 22 (2002) e1-e4
39. Taddei S., Virdis A., Ghiadoni L., Magagna A., Favilla S., Pompella A., and Salvetti A. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Hypertension 37 (2001) 943-948
40. Kelm M., Preik-Steinhoff H., Preik M., and Strauer B.E. Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial l-arginine-NO pathway. Cardiovasc. Res. 41 (1999) 765-772
41. Metzger I.F., Sertorio J.T.C., and Tanus-Santos J.E. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers. Acta Physiol. 188 (2006) 123-127
42. Barbosa Jr. F., Sertorio J.C.T., Gerlach R.F., and Tanus-Santos J.E. Clinical evidence for lead-induced inhibition of nitric oxide formation. Arch. Toxicol. 80 (2006) 811-816
43. Gladwin M.T., Crawford J.H., and Patel R.P. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic. Biol. Med. 36 (2004) 707-717
44. Lundberg J.O. Nitric oxide metabolites and cardiovascular disease markers, mediators, or both?. J. Am. Coll. Cardiol. 47 (2006) 580-581